Blenrep (Belantamab mafodotin) combinations approved by UK MHRA in relapsed/refractory multiple Myeloma

Hansoh Pharma announces NMPA has granted Breakthrough Therapy Designated drug for B7-H3-targeted antibody-drug conjugate HS-20093...

SYS6041 (Antibody-Drug Conjugate) obtains clinical trial approval in the U.S.

Reveal Genomics and Ona Therapeutics join forces to advance next-generation cancer treatment

BigHat Biosciences and Lilly collaborate to advance AI-driven antibody therapeutics

Lisata Therapeutics announces research license with Catalent